17 Aug Modern Sexual Wellness Services Supporting Health and Intimacy
Photo by Andrea Piacquadio[/caption]
Sexual wellness used to be a footnote in healthcare. If you had pain during sex, low desire, or a relationship that had gone quiet in the bedroom, the advice you got was usually some version of "relax" or "it's normal at your age." That is changing. Clinics, telehealth services, physical therapy practices, and educational platforms have all started treating intimacy as a legitimate part of health rather than a private embarrassment.
What follows is a look at several services approaching the same broad problem from different angles: research-backed writing, prescription care, hands-on rehabilitation, medical management through menopause, structured education, and play. According to the American Association of Sexuality Educators, Counselors and Therapists (AASECT), sexual health is a core component of overall wellbeing, and the majority of sexual difficulties have identifiable physical, hormonal, or psychological causes that respond to appropriate treatment.
[IMAGE GOES HERE]
Dr. Ottesen Kennair[/caption]
Leif Edward Ottesen Kennair, Phd
Professor, Department of Psychology
Norwegian University of Science and Technology
Trondheim, Norway
MedicalResearch.com: What is the background for this study?
Response: We have two important lines of research running parallel: 1) research into casual sex research. Over several papers inspired by previous evolutionary studies on casual sex we map the proximate mechanisms involved in regret. However, the adaptive function of regret: more adaptive future choices, was not addressed. This is something that most people and most regret researchers just take for granted. Bendixen et al 2017, Kennair et al 2016, 2018. 2) Research into how worry and rumination is not adaptive and how changing metacognitions about these mental processes are helpful here and now, and how discontinuing these processes is an efficient treatment of GAD and MDD. Kennair et al 2017. Solem et al 2019.
We found that it was important to question whether regret indeed was adaptive and affected more adaptive future short-term sexual choices. However, this demands a longitudinal design and such data are not easy to collect.
Dr. Kaufman[/caption]
Gregory Kaufman, M.D.
Senior Vice President
Global Clinical and Medical Affairs
Specialty at Lupin
MedicalResearch.com: What is the background for this study? Would you briefly explain what is meant by trichomoniasis? How common is this infection?
Response: The Phase 3 trial evaluated the effectiveness and safety of a single oral dose of Solosec® (secnidazole) 2g oral granules for the treatment of trichomoniasis in adult women. Top-line results were positive and showed that Solosec was generally well-tolerated.
Trichomoniasis is the most common non-viral sexually transmitted infection (STI) in the U.S., and is caused by a protozoan parasite called Trichomonas vaginalis.
